—Data from this real-world study revealed that patients with MS being treated with DMTs had a disproportionally higher number of cases of herpes zoster compared with patients treated with other ...

Using psychoactive substances for recreation, socialization or symptom self-management is common for many people living with ...

A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing whether this personalized treatment can slow or even ...

A new study compares CPZ and LPC models, creating a genetic roadmap to accelerate myelin regeneration therapies for Multiple ...

More than 1 million people across the United States live with multiple sclerosis (MS), a disease that affects the brain, ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

CMSC CEO Kathy Costello reflects on the progress made in MS care and what is still needed in the years to come.

The two main mouse models used to study myelin damage and repair in MS each replicate certain distinct biological features of ...

Transcriptomics of two prevailing models, cuprizone (CPZ) and lysophosphatidylcholine (LPC), reveal understanding of myelin loss and regeneration.